‘Bath Salts’: The Ever-Changing Landscape of Synthetic Cathinones
Tuesday April 24, 2018
Sponsored by the Division for Behavioral Pharmacology (BEH)
Co-sponsored by Division for Toxicology (TOX)
Scripps Research Institute
Harvard Medical School
Sponsored by La Jolla Alcohol Research, Inc.
The use of novel cathinone analogs, popularly referred to as ‘bath salts,’ has emerged as a substance abuse problem in the US in recent years. These substances are produced and distributed by clandestine markets in an attempt to circumvent their status as illegal substances. New synthetic cathinones that differ slightly in chemical structure and pharmacology from previous analogs, continue to show up in confiscated samples at an alarming rate. Synthetic cathinones share many of the neurochemical effects of psychomotor stimulants such as methamphetamine, cocaine, or MDMA, but differ on a range of behavioral and physiological endpoints.
Structure-Activity Relationships of 'Bath Salt' Constituents
- Virginia Commonwealth University
In Vivo Pharmacology of Novel Synthetic Cathinones
- University of North Texas Health Science Center
Locomotor Stimulant and Rewarding Effects of Inhaled 'Bath Salts'
- Scripps Research Institute
Neurochemical Deficits Induced by Synthetic Cathinones
- University of Utah
Reinforcing Effects of Novel Synthetic Cathinones and Their Mixtures
- University of Texas Health Science Center at San Antonio
Development and Preclinical Testing of a Vaccine for 3,4-Methylenedioxypyrovalerone ((R,S)-MDPV) Substance Use Disorders
- University of Arkansas for Medical Sciences